Anaylsis Tables

Analysis Table Shells
Table Shell 1: Description of samples at baseline surveys
Total

Intervention

Control

p-value

N

Provider-Level
Age (mean)
Female provider (%)
Ethnicity (%)
Hispanic
Non-Hispanic
Race* (%)
White
Black or African American
Asian
Native Hawaiian or other Pacific Islander
Native American or Alaska Native
Type of Clinician (%)
Ob/Gyn
Other physician
Nurse Practitioner
Certified nurse midwife
Physician’s Assistant
Number of years providing clinical care (mean)
Number of primary care outpatient settings
where currently practice (%)
1
2
3 or more
Hours spent in direct patient care (mean)
Percent of professional time spent in:
Primary care
Subspecialty care
Research
Teaching
Administration
Other
Years in practice at this clinic (mean)
Hours per week spent on outpatient care at this
clinic (mean)
Number of patients seen at this clinic in a
typical week (mean)
Number of adult female patients seen for
routine or well-woman exams in typical week
(mean)
Patient-Level
Age, years (mean)
Ethnicity (%)
Hispanic
Non-Hispanic

Attachment F2. Analysis tables

1

Total

Intervention

Control

p-value

N

Race* (%)
White
Black or African American
Asian
Native Hawaiian or other Pacific Islander
Native American or Alaska Native
Nativity (%)
Foreign-born
US-born
Language spoken at home (%)
English
Other
Highest level of school (%)
Less than high school
High school or GED
At least some college
Type of Health Insurance (%)
Private
Medicare
Medicaid
Military or VA
IL BCCP
No insurance / self-pay
Other
* Respondents were allowed to check all racial categories that applied.

Attachment F2. Analysis tables

2

Table Shell 2: Comparison of measures across control and intervention sites, percent and mean distributions

Total

Baseline Survey
Intervention
Control

p-value

Total

Patient-Level Measures
High Risk Behavior Scale
Pap Knowledge Scale
Previous HPV Test Use
HPV Knowledge Scale
HPV Testing Today – Attitude Scale
HPV Testing Today – Beliefs Scale
Screening Interval – Attitude Scale
Screening Interval – Beliefs Scale
Screening Interval – Intention
Provider-Level Measures
Importance of Annual Exam Scale
STD exposure
HPV Experience
Previous HPV training
Follow ACOG Guidelines
HPV Testing – Attitude Scale
HPV Testing – Beliefs Scale
HPV Testing – Social Support Scale
Screening Interval with Negative HPV and Normal Pap Results…
Attitude Scale
Beliefs Scale
Social Support Scale
Screening Interval with 3 Normal Paps…
Attitude Scale
Beliefs Scale
Social Support Scale
* Follow-up data are from the 18-month Patient Survey and the 12-month Provider Survey.

Attachment F2. Analysis tables

3

Follow-up Survey*
Intervention
Control

p-value

Table Shell 3: Bivariate and multivariate associations with increased screening interval
Bivariate Models
Estimate
p-value

Multivariate Model
Estimate
p-value

Clinic-Level Measures
Intervention Site
Control Site (reference)
Patient-Level Measures
Age, years
Race / Ethnicity
Hispanic
Black, non-Hispanic
Other, non-Hispanic
White, non-Hispanic (reference)
Nativity
Foreign-born
US-born (reference)
Language spoken at home
English (reference)
Other
Highest level of school
Less than high school
High school or GED (reference)
At least some college
High Risk Behavior Scale
Pap Knowledge Scale
Previous HPV Test Use
HPV Knowledge Scale
HPV Testing Today – Attitude Scale
HPV Testing Today – Beliefs Scale
Screening Interval – Attitude Scale
Screening Interval – Beliefs Scale
Screening Interval – Intention
Provider-Level Measures
Type of Provider
Ob/Gyn (reference)
Other physician
Nurse Practitioner
Certified nurse midwife
Physician’s Assistant
Importance of Annual Exam Scale
Risk Assessment Scale
STD exposure
HPV Experience
Previous HPV training
Follow ACOG Guidelines
HPV Testing – Attitude Scale
HPV Testing – Belief Scale
HPV Testing – Social Support Scale

Attachment F2. Analysis tables

4

Screening Interval with Negative HPV and Normal Pap Results…
Attitude Scale
Beliefs Scale
Social Support Scale
Screening Interval with 3 Normal Paps…
Attitude Scale
Beliefs Scale
Social Support Scale

Attachment F2. Analysis tables

5

Table Shell 4: Mean and standard deviation of provider attitude, belief and social support scales across the four provider survey waves
Baseline

12 months

36 months

HPV Testing
Attitude Scale
Intervention (mean / sd)
Control (mean / sd)
Belief Scale
Intervention (mean / sd)
Control (mean / sd)
Social Support Scale
Intervention (mean / sd)
Control (mean / sd)
Screening Interval with Negative HPV and Normal Pap Results
Attitude Scale
Intervention (mean / sd)
Control (mean / sd)
Beliefs Scale
Intervention (mean / sd)
Control (mean / sd)
Social Support
Intervention (mean / sd)
Control (mean / sd)
Screening Interval with 3 Normal Paps
Attitude Scale
Intervention (mean / sd)
Control (mean / sd)
Beliefs Scale
Intervention (mean / sd)
Control (mean / sd)
Social Support
Intervention (mean / sd)
Control (mean / sd)

Attachment F2. Analysis tables

6

p-value

Table Shell 5: Type of follow-up test or procedure performed for women with positive test results,
percent (N)

Type of follow-up test or procedure performed

HPV Pos /
Pap Abnormal
(N=)

HPV Pos /
Pap Normal
(N=)

HPV Neg /
Pap Abnormal
(N=)

Pap test
HPV DNA test
Colposcopy / Biopsy
Treatment (1)
Other diagnostic procedure (2)
No follow-up
(1) Treatment includes cone biopsy conization, cryotherapy, laser ablation, and cold knife cone.
(2) Other diagnostic procedure includes cervical ultrasound, excision of endocervical polyps,
cervicography, and endometrial sampling.

Attachment F2. Analysis tables

7

Table Shell 7: Percent distribution HPV vaccine attitudes and beliefs, baseline provider survey
Percent

N

Currently recommend the HPV vaccine
If YES, recommend HPV vaccine to the following patient.s…
Females 9-12 years of age
Females 13-26 years of age
Females 27 years of age and older
Males 9-12 years of age
Males 13-26 years of age
Males 27 years of age and older
If NO, plan to recommend the HPV vaccine
Plan to change cervical cancer screening and management for females
who are fully vaccinated with HPV vaccine
Yes
No
Don’t know
How often will you routinely screen for cervical cancer among females
that have been fully vaccinated with the HPV vaccine?
Annually
Every 2-3 years
Every 4-5 years
> 5 years
Will not be screened
Unknown
Will use the HPV test to manage abnormal Pap results for vaccinated
Patients are asking about HPV vaccination
Vaccinating female patients will result in…
Fewer numbers of abnormal Pap tests among vaccinated females
Agree
Disagree
Unsure
Fewer referrals for colposcopy among vaccinated females
Agree
Disagree
Unsure
Fewer CIN results
Agree
Disagree
Unsure

Attachment F2. Analysis tables

8